APA (7th ed.) Citation

D, Y., S, H., Y, D., T, N., H, O., S, K., . . . Y, S. (2021). Author Correction: PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma. Scientific reports, 11(1), 21253. https://doi.org/10.1038/s41598-021-00915-1

Chicago Style (17th ed.) Citation

D, Yokoyama, et al. "Author Correction: PTEN Is a Predictive Biomarker of Trastuzumab Resistance and Prognostic Factor in HER2-overexpressing Gastroesophageal Adenocarcinoma." Scientific Reports 11, no. 1 (2021): 21253. https://doi.org/10.1038/s41598-021-00915-1.

MLA (9th ed.) Citation

D, Yokoyama, et al. "Author Correction: PTEN Is a Predictive Biomarker of Trastuzumab Resistance and Prognostic Factor in HER2-overexpressing Gastroesophageal Adenocarcinoma." Scientific Reports, vol. 11, no. 1, 2021, p. 21253, https://doi.org/10.1038/s41598-021-00915-1.